Pharmaceutical

Bruker to buy cell biology company PhenomeX for $108m

Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.

Aug 18, 2023 - 20:00
Bruker to buy cell biology company PhenomeX for $108m
Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.
Read the original article

Tags:

Previous Article

Coeptis licenses Deverra Therapeutics’ clinical stage assets

Next Article

How competitive intelligence can give pharma companies an edge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Harmony wins orphan drug tag for pitolisant to treat Prader-Willi syndrome 

Harmony wins orphan drug tag for pitolisant to treat Pr...

Feb 22, 2024

Top 20 biopharmas’ market cap up 4.3% in Q2 2024 as GLP-1 drug innovators hold top spots

Top 20 biopharmas’ market cap up 4.3% in Q2 2024 as GLP...

Aug 21, 2024

Orion sees highest patent filings and grants during May in Q2 2024

Orion sees highest patent filings and grants during May...

Jul 22, 2024